AIM
UTHR icon

Achmea Investment Management’s United Therapeutics UTHR Stock Holding History

Achmea Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.9M Buy
38,530
+16,654
+76% +$9.38M 0.52% 57
2026
Q1 		$13M Buy
21,876
+1,247
+6% +$621K 0.34% 65
2025
Q4 		$10.1M Sell
20,629
-3,476
-14% -$1.62M 0.26% 73
2025
Q3 		$10.1M Sell
24,105
-13,709
-36% -$4.61M 0.13% 163
2025
Q2 		$10.9M Sell
37,814
-21,366
-36% -$6.39M 0.14% 168
2025
Q1 		$18.2M Buy
59,180
+22,434
+61% +$7.69M 0.27% 112
2024
Q4 		$13M Buy
36,746
+12,627
+52% +$4.64M 0.21% 127
2024
Q3 		$8.64M Buy
+24,119
New +$8.15M 0.14% 174
2023
Q3 		– Sell
-4,837
Closed -$1.07M – 627
2023
Q2 		$1.07M Sell
4,837
-93
-2% -$20.6K 0.02% 419
2023
Q1 		$1.1M Buy
+4,930
New +$1.22M 0.03% 385
2020
Q3 		– Sell
-872
Closed -$106K – 545
2020
Q2 		$106K Hold
872
– – ﹤0.01% 274
2020
Q1 		$83K Buy
+872
New +$82.9K ﹤0.01% 235
2019
Q3 		– Sell
-1,928
Closed -$150K – 526
2019
Q2 		$150K Sell
1,928
-10,047
-84% -$940K 0.01% 506
2019
Q1 		$1.41M Hold
11,975
– – 0.06% 292
2018
Q4 		$1.3M Buy
11,975
+1,928
+19% +$224K 0.06% 287
2018
Q3 		$1.28M Sell
10,047
-1,983
-16% -$245K 0.05% 338
2018
Q2 		$1.36M Sell
12,030
-5,212
-30% -$573K 0.05% 329
2018
Q1 		$1.93M Buy
17,242
+5,567
+48% +$707K 0.07% 293
2017
Q4 		$1.73M Sell
11,675
-4,533
-28% -$576K 0.06% 317
2017
Q3 		$1.9M Buy
16,208
+886
+6% +$113K 0.11% 241
2017
Q2 		$1.99M Sell
15,322
-1,643
-10% -$205K 0.12% 225
2017
Q1 		$2.3M Buy
+16,965
New +$2.57M 0.11% 250

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Achmea Investment Management's UTHR Position: Q2 2026 in Review

Achmea Investment Management increased its United Therapeutics (UTHR) stake by 76% in Q2 2026, buying an estimated $9.38M and bringing the position to 38,530 shares worth $20.9M. The position accounts for 0.52% of the portfolio, ranked #57.

Achmea Investment Management first reported a position in UTHR in Q1 2017 and has held it in 22 quarters since. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Achmea Investment Management held 38,530 shares of United Therapeutics worth $20.9M as of Q2 2026.
  • Achmea Investment Management bought 16,654 United Therapeutics shares in Q2 2026, an estimated $9.38M.
  • United Therapeutics made up 0.52% of Achmea Investment Management's portfolio in Q2 2026, its #57 holding.
  • Achmea Investment Management first reported a position in United Therapeutics in Q1 2017 and has held it in 22 quarters since.
  • 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Achmea Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.